Clinical Trial Update: Treatment of Resectable Malignant Brain Tumors [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating treatment for resectable malignant brain tumors sponsored by MD Anderson Cancer Center was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Tumor | Phase 4 | Status: TERMINATED